Skip to main content
. 2017 Aug 24;8(47):83207–83224. doi: 10.18632/oncotarget.20544

Figure 5. HT and cetuximab combination modulate the cell cycle checkpoint proteins in colorectal cancer cells.

Figure 5

HT-29 (A, B, C), and WiDr (D, E, F) cells were exposed to HT or cetuximab, alone or in combination in presence of EGF for 48 h and the cell cycle checkpoint proteins were analyzed by western blot.